Bloomberg -- Sanofi-Aventis SA, France’s biggest drugmaker, plans further expense reductions in areas such as marketing to offset lower revenue that’s resulting from health- care reforms in Europe.
Bloomberg -- Sanofi-Aventis SA, France’s biggest drugmaker, plans further expense reductions in areas such as marketing to offset lower revenue that’s resulting from health- care reforms in Europe.
